These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24495507)

  • 1. Acute and long term mineral metabolism adaptation in living kidney donors: a prospective study.
    Ponte B; Trombetti A; Hadaya K; Ernandez T; Fumeaux D; Iselin C; Martin PY; de Seigneux S
    Bone; 2014 May; 62():36-42. PubMed ID: 24495507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
    Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
    Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral nephrectomy causes an early abrupt decrease in plasma arginine and simultaneous reduction in glomerular filtration rate in living kidney donors.
    Zunić G; Tomić A; Spasić S
    Clin Biochem; 2013 Oct; 46(15):1394-8. PubMed ID: 23669210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living kidney donation does not adversely affect serum calcification propensity and markers of vascular stiffness.
    de Seigneux S; Ponte B; Berchtold L; Hadaya K; Martin PY; Pasch A
    Transpl Int; 2015 Sep; 28(9):1074-80. PubMed ID: 25903063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Markers of Mineral Metabolism After Living Kidney Donation.
    Tan SJ; Hewitson TD; Hughes PD; Holt SG; Toussaint ND
    Transplant Direct; 2017 Apr; 3(4):e150. PubMed ID: 28405606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23/klotho axis in chronic kidney disease.
    Nitta K; Nagano N; Tsuchiya K
    Nephron Clin Pract; 2014; 128(1-2):1-10. PubMed ID: 25402964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
    Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
    Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of kidney donation on bone mineral metabolism.
    Hiemstra TF; Smith JC; Lim K; Xu D; Kulkarni S; Bradley JA; Paapstel K; Schoenmakers I; Bradley JR; Tomlinson L; McEniery CM; Wilkinson IB
    PLoS One; 2020; 15(7):e0235082. PubMed ID: 32634148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.
    Takahashi H; Komaba H; Takahashi Y; Sawada K; Tatsumi R; Kanai G; Suzuki H; Kakuta T; Fukagawa M
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E652-8. PubMed ID: 24476081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
    Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
    Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
    Prié D; Friedlander G
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.
    Lin HH; Liou HH; Wu MS; Lin CY; Huang CC
    Nephrology (Carlton); 2014 Nov; 19(11):672-8. PubMed ID: 25113414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mineral metabolism in patients on chronic peritoneal dialysis].
    Ceballos O ML; Rojo L A; Azócar P M; Ibacache M MJ; Delucchi B A; Quiroz Z L; Irarrázabal M C; Delgado B I; Ugarte P F; Cano Sch F
    Rev Chil Pediatr; 2014 Feb; 85(1):31-9. PubMed ID: 25079181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
    Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
    Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective controlled study of living kidney donors: three-year follow-up.
    Kasiske BL; Anderson-Haag T; Israni AK; Kalil RS; Kimmel PL; Kraus ES; Kumar R; Posselt AA; Pesavento TE; Rabb H; Steffes MW; Snyder JJ; Weir MR
    Am J Kidney Dis; 2015 Jul; 66(1):114-24. PubMed ID: 25795073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.